
Auteur G. MIDGETTE
|
Documents disponibles écrits par cet auteur (10)

* Research Questions: What types of cannabis products are produced and sold in Washington State? What is the size of the cannabis market in Washington State three years after licensing cannabis production and sales for nonmedical purposes? * [...]
B. KILMER ; J. P. CAULKINS ; G. MIDGETTE ; L. DAHLKEMPER ; R. J. MACCOUN ; R. L. PACULA | 2013
RapportIn 2012, Washington state voters passed Initiative 502 (I-502), which removed the prohibition on the production, distribution, and possession of marijuana for nonmedical purposes and required the state to regulate and tax a new marijuana industr[...]
J. P. CAULKINS ; B. KILMER ; P. H. REUTER ; G. MIDGETTE | 2015
Dans Addiction (Vol.110, n°5, May 2015) Article : PériodiqueAims: Drug policy strategies and discussions often use prevalence of drug use as a primary performance indicator. However, three other indicators are at least as relevant: the number of heavy users, total expenditures and total amount consumed. [...]
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. REUTER | 2015
RapportMarijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]
G. MIDGETTE ; P. REUTER | 2020
Dans Prevention Science (Vol.21, n°1, January 2020) Article : PériodiqueAs US states move toward various forms of adult access to cannabis, there has been a great interest in measuring the impact of such changes on adolescent cannabis use. Two recent prominent analyses have used Monitoring the Future (MTF), a nation[...]
P. REUTER ; J. P. CAULKINS ; G. MIDGETTE | 2021
Dans Addiction (Vol.116, n°10, October 2021) Article : PériodiqueBACKGROUND: Globally, heroin and other opioids account for more than half of deaths and years-of-life-lost due to drug use and comprise one of the four major markets for illegal drugs. Having sound estimates of the number of problematic heroin u[...]
J. P. CAULKINS ; B. KILMER ; M. A. R. KLEIMAN ; R. J. MACCOUN ; G. MIDGETTE ; P. OGLESBY ; R. L. PACULA ; P. H. REUTER | 2015
RapportMarijuana legalization is a controversial and multifaceted issue that is now the subject of serious debate. Since 2012, four U.S. states have passed ballot initiatives to remove prohibition and legalize a for-profit commercial marijuana industry[...]
R. SMART ; J. P. CAULKINS ; B. KILMER ; S. DAVENPORT ; G. MIDGETTE | 2017
Dans Addiction (Vol.112, n°12, December 2017) Article : PériodiqueAims: To (1) assess trends and variation in the market share of product types and potency sold in a legal cannabis retail market and (2) estimate how potency and purchase quantity influence price variation for cannabis flower. Design: Secondar[...]
B. KILMER ; S. S. EVERINGHAM ; J. P. CAULKINS ; G. MIDGETTE ; R. L. PACULA ; P. H. REUTER ; R. M. BURNS ; B. HAN ; R. LUNDBERG | 2014
RapportIn January 2012, the U.S. White House Office of National Drug Control Policy (ONDCP) asked RAND to generate national estimates of the total number of users, total expenditures, and total consumption for four illicit drugs from 2000 to 2010: coca[...]
Research questions: How many people are using cocaine (including crack), heroin, marijuana, and methamphetamine in the United States? How much are they using? How much money are they spending? How have these quantities changed over time? [...]